Saleh, R.; Taha, R.Z.; Sasidharan Nair, V.; Alajez, N.M.; Elkord, E.
PD-L1 Blockade by Atezolizumab Downregulates Signaling Pathways Associated with Tumor Growth, Metastasis, and Hypoxia in Human Triple Negative Breast Cancer. Cancers 2019, 11, 1050.
https://doi.org/10.3390/cancers11081050
AMA Style
Saleh R, Taha RZ, Sasidharan Nair V, Alajez NM, Elkord E.
PD-L1 Blockade by Atezolizumab Downregulates Signaling Pathways Associated with Tumor Growth, Metastasis, and Hypoxia in Human Triple Negative Breast Cancer. Cancers. 2019; 11(8):1050.
https://doi.org/10.3390/cancers11081050
Chicago/Turabian Style
Saleh, Reem, Rowaida Z. Taha, Varun Sasidharan Nair, Nehad M. Alajez, and Eyad Elkord.
2019. "PD-L1 Blockade by Atezolizumab Downregulates Signaling Pathways Associated with Tumor Growth, Metastasis, and Hypoxia in Human Triple Negative Breast Cancer" Cancers 11, no. 8: 1050.
https://doi.org/10.3390/cancers11081050
APA Style
Saleh, R., Taha, R. Z., Sasidharan Nair, V., Alajez, N. M., & Elkord, E.
(2019). PD-L1 Blockade by Atezolizumab Downregulates Signaling Pathways Associated with Tumor Growth, Metastasis, and Hypoxia in Human Triple Negative Breast Cancer. Cancers, 11(8), 1050.
https://doi.org/10.3390/cancers11081050